Delaware 2023-2024 Regular Session

Delaware Senate Bill SB101

Introduced
4/26/23  
Introduced
4/26/23  

Caption

An Act To Amend Title 16 Of The Delaware Code Relating To The Uniform Controlled Substances Act.

Impact

If enacted, SB101 would recalibrate the thresholds for legal penalties associated with fentanyl offenses. Specifically, it categorizes drug quantities into several tiers, reflecting the severity and potential harm of possessing varying amounts of fentanyl. This legislation is likely to influence law enforcement and the judicial system's approach to drug offenses, emphasizing a more stringent stance against fentanyl-related crimes, which proponents argue is critical given the ongoing opioid crisis and the specific risks of fentanyl exposure.

Summary

Senate Bill 101 aims to amend the Uniform Controlled Substances Act in Delaware by establishing specific quantity tiers for drug offenses related to fentanyl. Given the increasing concerns regarding the potency and associated fatalities of fentanyl, this bill is designed to enhance the legal framework surrounding controlled substances, recognizing the unique dangers posed by fentanyl compared to other substances in similar categories. The changes are an urgent response to the rising number of related deaths and health issues across various communities within the state of Delaware.

Sentiment

The sentiment surrounding SB101 appears to be largely supportive among legislators and community advocates who emphasize the necessity of addressing the fentanyl crisis. Many view the bill as a proactive measure to tackle an urgent public health issue. However, some concern could exist regarding potential over-criminalization or lack of support services for individuals struggling with substance abuse, suggesting that while the intent of the bill is positive, discussions around its implementation need careful consideration.

Contention

A notable point of contention could arise regarding how the implementation of the new quantity tiers might influence sentencing and rehabilitation opportunities for individuals convicted of drug offenses. While proponents argue for stricter penalties as a deterrent against fentanyl distribution and use, opponents might highlight the importance of balancing public safety with compassionate responses towards addiction. There may also be discussions on whether the bill addresses the root causes of drug addiction or merely enhances punitive measures without providing adequate support systems.

Companion Bills

No companion bills found.

Previously Filed As

DE SB189

An Act To Amend Title 16 Of The Delaware Code Relating To The Uniform Controlled Substances Act And Drug Testing Strips.

DE SB215

An Act To Amend Title 16 Of The Delaware Code Relating To State Inspections Of Long-term Care Facilities.

DE SB165

An Act To Amend Title 24 Of The Delaware Code Relating To Pharmacy.

DE SB70

An Act To Amend Title 24 Of The Delaware Code Relating To Genetic Counselors.

DE SB108

An Act To Amend Title 11 Of The Delaware Code Relating To The Gold Alert Program For Certain Missing Persons.

DE SB63

An Act To Amend Title 9 Of The Delaware Code Relating To Farms.

DE SB100

An Act To Amend Title 11 Of The Delaware Code Relating To Designation Of Violent Felonies.

DE SB38

An Act To Amend Title 16 Of The Delaware Code Relating To Retired Law-enforcement Animals.

DE HB282

An Act To Amend Title 29 Of The Delaware Code Relating To The State Employee Benefits Committee.

DE HB281

An Act To Amend Title 29 Of The Delaware Code Relating To State Health Care Insurance.

Similar Bills

MS HB232

Uniform Controlled Substances Act; revise schedules.

NJ S617

Adds illicit fentanyls to Schedule I in the "New Jersey Controlled Dangerous Substances Act."

NJ A2119

Adds illicit fentanyls to Schedule I in the "New Jersey Controlled Dangerous Substances Act."

NJ S2155

Adds illicit fentanyls to Schedule I in the "New Jersey Controlled Dangerous Substances Act."

NJ A998

Adds illicit fentanyls to Schedule I in the "New Jersey Controlled Dangerous Substances Act."

IN HB1182

Regulation of controlled substances.

NJ S3325

Enhances penalties for distribution and manufacture of certain amounts of fentanyl.

OR SB988

Relating to fentanyl; declaring an emergency.